SCHEMBL19921159

SCHEMBL19921159

CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(O)CC3)cc2)nc2ccn(C)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 9/20 0.58
▸ TTK P33981 5/20 0.54
▸ FES P07332 2/20 0.53
▸ FLT3 P36888 2/20 0.53
▸ ALK Q9UM73 8/20 0.49
▸ INSR P06213 3/20 0.46
▸ GAK O14976 2/20 0.46
▸ IGF1R P08069 2/20 0.46
▸ INSRR P14616 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ LTK P29376 2/20 0.46
▸ CLK1 P49759 2/20 0.46
▸ TNK2 Q07912 2/20 0.46
▸ TNK1 Q13470 2/20 0.46
▸ PTK2B Q14289 2/20 0.46
▸ CDK7 P50613 2/20 0.46
▸ FGFR1 P11362 2/20 0.46
▸ FGFR2 P21802 2/20 0.46
▸ FGFR4 P22455 2/20 0.46
▸ FGFR3 P22607 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19921167 0.92 PTK2 (0.51) PTK2TTKFESFLT3ALK
SCHEMBL19921089 0.90 AXL (0.53) PTK2TTKFESFLT3ALK
SCHEMBL19921119 0.88 PTK2 (0.46) PTK2TTKFESFLT3ALK
SCHEMBL19921113 0.85 TTK (0.63) PTK2TTKFESFLT3ALK
SCHEMBL21100192 0.84 ALK (0.65) PTK2TTKFESFLT3ALK
SCHEMBL22730040 0.84 IRAK4 (0.42) PTK2TTKFESFLT3TNK2
SCHEMBL22730041 0.83 IRAK4 (0.45) PTK2ALKTNK2FGFR1FGFR2
SCHEMBL19921085 0.83 PTK2 (0.56) PTK2ALKINSRIGF1REGFR
SCHEMBL19921112 0.82 PTK2 (0.62) PTK2ALKINSRIGF1RFGFR4
SCHEMBL19921150 0.82 PLK1 (0.46) PTK2FLT3INSRIGF1RPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290420-B1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF UNIV XIAMEN (CN) 2020-12-09 — — EP claimed
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF XIAMEN UNIVERSITY (CN) 2018-11-01 — — US claimed
EP-3290420-A1 PYRIMIDINE PYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF Xiamen University (CN) 2018-03-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312508-A1 PYRIMIDOPYRROLE COMPOUNDS, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF TPMT, DHPS, TYMP PTK2 4325/4885TTK 1018/4885FES 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback